# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-26-125062
Filing Date
2026-03-26
Accepted
2026-03-26 07:10:11
Documents
46
Period of Report
2026-03-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | mplt-20260326.htm iXBRL | 8-K | 48913
2 | EX-99.1 | mplt-ex99_1.htm | EX-99.1 | 143232
3 | EX-99.2 | mplt-ex99_2.htm | EX-99.2 | 45743
4 | GRAPHIC | img164021786_0.gif | GRAPHIC | 3945
5 | GRAPHIC | mplt-ex99_2s1.jpg | GRAPHIC | 163206
6 | GRAPHIC | mplt-ex99_2s2.jpg | GRAPHIC | 714993
7 | GRAPHIC | mplt-ex99_2s3.jpg | GRAPHIC | 355457
8 | GRAPHIC | mplt-ex99_2s4.jpg | GRAPHIC | 357862
9 | GRAPHIC | mplt-ex99_2s5.jpg | GRAPHIC | 202542
10 | GRAPHIC | mplt-ex99_2s6.jpg | GRAPHIC | 465772
11 | GRAPHIC | mplt-ex99_2s7.jpg | GRAPHIC | 444551
12 | GRAPHIC | mplt-ex99_2s8.jpg | GRAPHIC | 407180
13 | GRAPHIC | mplt-ex99_2s9.jpg | GRAPHIC | 345189
14 | GRAPHIC | mplt-ex99_2s10.jpg | GRAPHIC | 381779
15 | GRAPHIC | mplt-ex99_2s11.jpg | GRAPHIC | 361103
16 | GRAPHIC | mplt-ex99_2s12.jpg | GRAPHIC | 362628
17 | GRAPHIC | mplt-ex99_2s13.jpg | GRAPHIC | 376346
18 | GRAPHIC | mplt-ex99_2s14.jpg | GRAPHIC | 415889
19 | GRAPHIC | mplt-ex99_2s15.jpg | GRAPHIC | 333715
20 | GRAPHIC | mplt-ex99_2s16.jpg | GRAPHIC | 373871
21 | GRAPHIC | mplt-ex99_2s17.jpg | GRAPHIC | 298065
22 | GRAPHIC | mplt-ex99_2s18.jpg | GRAPHIC | 170138
23 | GRAPHIC | mplt-ex99_2s19.jpg | GRAPHIC | 361900
24 | GRAPHIC | mplt-ex99_2s20.jpg | GRAPHIC | 363962
25 | GRAPHIC | mplt-ex99_2s21.jpg | GRAPHIC | 405849
26 | GRAPHIC | mplt-ex99_2s22.jpg | GRAPHIC | 390904
27 | GRAPHIC | mplt-ex99_2s23.jpg | GRAPHIC | 356914
28 | GRAPHIC | mplt-ex99_2s24.jpg | GRAPHIC | 170831
29 | GRAPHIC | mplt-ex99_2s25.jpg | GRAPHIC | 329902
30 | GRAPHIC | mplt-ex99_2s26.jpg | GRAPHIC | 335883
31 | GRAPHIC | mplt-ex99_2s27.jpg | GRAPHIC | 303920
32 | GRAPHIC | mplt-ex99_2s28.jpg | GRAPHIC | 335510
33 | GRAPHIC | mplt-ex99_2s29.jpg | GRAPHIC | 169594
34 | GRAPHIC | mplt-ex99_2s30.jpg | GRAPHIC | 379544
35 | GRAPHIC | mplt-ex99_2s31.jpg | GRAPHIC | 276495
36 | GRAPHIC | mplt-ex99_2s32.jpg | GRAPHIC | 311341
37 | GRAPHIC | mplt-ex99_2s33.jpg | GRAPHIC | 153040
38 | GRAPHIC | mplt-ex99_2s34.jpg | GRAPHIC | 432285
| Complete submission text file | 0001193125-26-125062.txt |  | 16367143

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
39 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | mplt-20260326.xsd | EX-101.SCH | 26004
49 | EXTRACTED XBRL INSTANCE DOCUMENT | mplt-20260326_htm.xml | XML | 4935

Mailing Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-839-4360
MapLight Therapeutics, Inc. (Filer) CIK: 0001770069 (see all company filings)

EIN.: 832163243 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42914 | Film No.: 26794308
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)